PE/VC Reset: Q1 2026 Values Down 48%
Key Questions
What were the key statistics for India PE/VC deals in Q1 2026?
India PE/VC recorded a record 360 deals worth $13.1 billion. Deal values dropped 48% due to caution on megadeals, signaling a shift to mid-market focus amid global caution.
Why did PE/VC deal values decline sharply in Q1 2026?
Values fell 48% primarily due to a slowdown in billion-dollar megadeals. Investors showed caution, leading to higher volumes but lower overall values in India's deal market.
How did the healthcare and pharma sector perform in Q1 2026 PE/VC deals?
The sector maintained steady momentum with 78 deals worth $1.9 billion. It remained resilient despite broader market caution on large deals.
What trends are indicated by the Q1 2026 PE/VC activity?
The data signals a 'great PE reset' with a move away from billion-dollar bets toward mid-market deals. This reflects global caution and a focus on smaller, steadier investments.
Are there emerging complexities in India M&A deals related to PE/VC?
India M&A deals are growing more complex, with transactional risk insurance surging, as per Marsh report. This aligns with the cautious approach seen in Q1 2026 PE/VC trends.
India PE/VC hit record deal volumes but values dropped sharply due to caution on megadeals; $13.1B across 360 deals, healthcare/pharma steady at $1.9B/78 deals. Signals mid-market focus amid global caution.